乳鐵蛋白市場－全球產業規模、佔有率、趨勢、機會、預測：按功能、應用、區域和競爭格局分類，2021-2031年

全球乳鐵蛋白市場預計將從 2025 年的 1.4839 億美元成長到 2031 年的 2.4914 億美元，複合年成長率為 9.02%。

這種分子量為 80 kDa 的鐵結合糖蛋白天然存在於哺乳動物的乳汁和其他體液中，因其廣泛的生物學功能而備受重視，包括免疫調節、抗發炎、抗病毒和抗菌特性。市場成長主要得益於消費者對其健康益處的認知不斷提高，尤其是其增強鐵吸收和支持免疫系統的能力。此外，乳鐵蛋白在藥品、營養補充品、機能性食品和嬰兒配方奶粉（乳鐵蛋白在其中發揮模擬母乳成分的作用）中的應用日益廣泛，也顯著推動了該行業的成長趨勢。

儘管有這些有利因素，但由於從天然資源中提取和提純乳鐵蛋白的成本高昂，全球乳鐵蛋白產業仍面臨許多挑戰。這些複雜的製程需要高度專業化的設備和技術，這限制了最終產品生產的規模化和價格的降低。關於此生產流程的原料需求，美國農業部海外農業局指出，預計到2025市場年度，紐西蘭的生乳產量將達到2,170萬噸，其中相當一部分將用於生產乳鐵蛋白等高附加價值乳製品成分。

市場促進因素

隨著消費者對乳鐵蛋白健康益處的認知不斷加深，對營養強化和免疫力增強產品的需求日益成長，對整個產業產生了顯著影響。在對原料品質和預防醫學的濃厚興趣驅動下，製造商正在開發利用這種糖蛋白既定功效的產品。 Frizlandcampina Ingredients 於 2025 年 1 月發布的一份報告也印證了這一趨勢：超過 59% 的 12 個月以下嬰兒的父母希望增強孩子的免疫力，這促使食品中添加有益成分。消費者對乳鐵蛋白的強烈需求正推動其應用範圍從傳統的營養補充劑擴展到機能飲料和食品領域，使其應用更加多元化。

推動市場成長的另一個主要因素是嬰兒配方奶粉中乳鐵蛋白需求的不斷成長。這是因為乳鐵蛋白能夠促進鐵的吸收、增強嬰兒免疫力，並模擬母乳中的成分。這種需求的激增促使該領域的生產和創新獲得了大量投資。根據 Mejerimedier 於 2024 年 9 月報道，Arla Foods 正在擴建其位於丹麥霍爾斯特布羅的 HOCO 工廠，新工廠將於 2025 年開工建設，建成後將使奶粉日產量增加約 180 公斤，尤其有助於提高乳鐵蛋白浸出液的產量。鑑於市場對嬰兒營養需求的樂觀情緒日益高漲，細胞農業投資公司 Agronomics 於 2026 年 1 月向澳大利亞生物技術公司 All G 追加投資 300 萬澳元，作為一項 1000 萬澳元資金籌措計劃的一部分，該計劃旨在擴大基於微發酵的乳鐵蛋白生產。

市場挑戰

生產成本不斷上漲是全球乳鐵蛋白產業擴張的主要障礙。從哺乳動物乳汁（其主要天然來源）中提取和提純乳鐵蛋白需要複雜的製程、大量的資金投入以及高度專業化的技術和設備。因此，高昂的成本最終會轉嫁到含乳鐵蛋白的產品上，使其價格昂貴，難以惠及更廣泛的消費者群體，尤其是對價格敏感的消費者。此外，提取技術的高度專業化意味著擴大生產規模需要先進的設施和巨額的資本投資，這進一步限制了產業成長。

國際酪農聯合會（IDF）在其2025年全球酪農情勢報告中指出，2024年全球各類原乳產量增加了2.2%。雖然這表明基礎原料​​供應有所增加，但從如此龐大的奶量中提取乳鐵蛋白等高純度成分仍然存在許多根本性難題和巨大成本，這些仍然是重要的障礙。這些長期存在的操作複雜性使得成本效益高的規模化生產難以實現，從而抑制了市場整體成長的潛力。

市場趨勢

乳鐵蛋白在個人保健產品和藥用化妝品中的應用日益廣泛，這已成為業界的一大趨勢，而這得益於人們對其多種生物學功能的科學認知不斷加深。持續的研究揭示了乳鐵蛋白強大的抗氧化、抗炎和抗菌特性，使其在口腔護理、頭髮護理和護膚配方中備受關注。製造商正利用乳鐵蛋白的天然來源和多功能性，開發各種皮膚問題的解決方案，涵蓋抗衰老護理到痤瘡治療等領域。這一向美容和健康領域的轉變得到了大量研究的支持。正如森永乳業株式會社在其網站上於2025年12月指出的那樣，目前全球已有超過9000篇科學論文報導了乳鐵蛋白在傳統營養用途之外的廣泛功能和應用。

同時，受消費者對低致敏性、符合道德規範且永續的原料需求日益成長的推動，整個產業正經歷一場變革。微發酵技術在生產乳鐵蛋白方面發揮著至關重要的作用，它無需依賴動物來源，為傳統的牛萃取物提供了可靠且可擴展的替代方案。隨著各公司努力滿足現代消費者的道德和飲食偏好，這一趨勢正在吸引大量投資，並開拓新的商業性潛力。例如，2025年1月FoodNavigator-USA的一份報告指出，Strive Nutrition計劃於2025年第一季推出一款含有TurtleTree非動物源乳鐵蛋白的即溶蛋白粉和機能飲料，凸顯了這些前沿替代品在市場上的高度認可。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球乳鐵蛋白市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 功能分類（鐵吸收、抗發炎、保護腸內菌叢、抗菌、刺激免疫細胞、抗氧化）
  • 按應用領域（食品和飲料、嬰兒配方奶粉、運動和機能性食品、藥品、個人保健產品、動物飼料）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美乳鐵蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲乳鐵蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區乳鐵蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲乳鐵蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲乳鐵蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球乳鐵蛋白市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Hilmar Cheese Co Inc
• Pharming Group NV
• Royal FrieslandCampina NV
• Synlait Milk Ltd
• Ingredia SA
• MP Biomedicals LLC
• Tatura Milk Industries Ltd
• Glanbia PLC
• APS BioGroup Inc
• ProHealth Care Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global lactoferrin market is expected to expand from USD 148.39 million in 2025 to USD 249.14 million by 2031, representing a compound annual growth rate of 9.02%. This 80 kDa iron-binding glycoprotein, found naturally in mammalian milk and other bodily secretions, is highly valued for its extensive biological functions, which include immunomodulatory, anti-inflammatory, antiviral, and antimicrobial effects. Market growth is heavily fueled by rising consumer knowledge of its health advantages, especially concerning improved iron uptake and immune system support. Additionally, the increasing use of lactoferrin in pharmaceuticals, dietary supplements, functional foods, and infant formula-where it replicates elements of human breast milk-greatly contributes to the industry's upward trajectory.

Even with these positive growth factors, the worldwide lactoferrin industry encounters a significant hurdle due to the steep expenses involved in extracting and purifying the compound from natural sources. These complex procedures demand highly specialized equipment and technology, which ultimately restricts both the scalability and affordability of the end products. Highlighting the raw material requirements of this manufacturing process, the USDA Foreign Agricultural Service noted that fluid milk production in New Zealand reached an estimated 21.7 million metric tons for the 2025 market year, with a substantial share allocated to creating value-added dairy components like lactoferrin.

Market Driver

Growing consumer knowledge regarding the health advantages of lactoferrin is significantly shaping the industry by driving the need for nutritionally enriched and immune-boosting goods. A strong emphasis on ingredient excellence and preventive health measures has led manufacturers to develop items that utilize the established benefits of this glycoprotein. Highlighting this trend, a January 2025 report from FrieslandCampina Ingredients revealed that more than 59% of parents with infants under twelve months old wanted to enhance their child's immune system, prompting the addition of these helpful ingredients into dietary products. This strong buyer enthusiasm is pushing lactoferrin beyond conventional supplements and into the realm of functional beverages and foods, diversifying its practical uses.

Another major catalyst for market growth is the escalating need for lactoferrin in baby formula, driven by its capacity to enhance iron absorption, bolster infant immunity, and replicate components found in breast milk. This surge has led to substantial financial backing for manufacturing and innovation within the sector. As reported by Mejerimedier in September 2024, Arla Foods is enlarging its HOCO facility in Holstebro, Denmark, where construction starting in 2025 will yield a new plant capable of boosting powder output by roughly 180 kg daily to specifically increase lactoferrin eluate production. Emphasizing wider market optimism regarding early life nutrition demands, cellular agriculture investment firm Agronomics injected an additional AUD 3 million into Australian biotechnology company All G in January 2026 as part of a larger AUD 10 million funding initiative aimed at scaling up precision fermentation-based lactoferrin production.

Market Challenge

Elevated manufacturing expenses present a formidable obstacle to the expansion of the worldwide lactoferrin industry. Extracting and refining this ingredient from its primary natural source, mammalian milk, involves complex procedures that demand significant financial backing and highly specialized technological equipment. Consequently, the high costs are passed down to lactoferrin-infused items, reducing their affordability and restricting their reach among wider audiences, especially within demographics highly sensitive to pricing. Additionally, because the extraction techniques are so specialized, scaling up operations is constrained by the need for advanced facilities and massive capital investments.

The International Dairy Federation noted in its 2025 World Dairy Situation Report that the worldwide output of raw, unprocessed milk across all species increased by 2.2% during 2024. Even though this points to an expanding supply of foundational raw materials, the fundamental difficulties and steep expenses associated with extracting a highly pure component like lactoferrin from such vast quantities remain a major hurdle. These enduring operational complexities make it difficult to achieve cost-effective mass production, ultimately slowing down the broader growth potential of the market.

Market Trends

A prominent trend in the industry is the incorporation of lactoferrin into personal care items and cosmeceuticals, a shift motivated by a deepening scientific grasp of its varied biological functions. The ingredient is becoming increasingly attractive for oral care, haircare, and skincare formulations as ongoing studies reveal its potent antioxidant, anti-inflammatory, and antimicrobial traits. Producers are capitalizing on its natural derivation and versatile advantages to formulate solutions for diverse dermatological issues, spanning from anti-aging treatments to acne management. This transition into beauty and wellness sectors is supported by extensive research; as noted on the Morinaga Milk Industry website in December 2025, more than 9,000 global scientific publications now document lactoferrin's broad capabilities and uses outside of standard nutritional applications.

At the same time, the industry is being transformed by a surging consumer appetite for animal-free lactoferrin, driven by a desire for hypoallergenic, ethically sourced, and sustainable components. The use of precision fermentation technology plays a crucial role in creating lactoferrin without relying on animal origins, providing a reliable and scalable substitute for conventional bovine extraction. This movement is drawing significant financial investment and unlocking novel market avenues as businesses strive to align with modern shoppers' ethical and dietary preferences. Illustrating this commercial momentum, a January 2025 FoodNavigator-USA report noted that Strive Nutrition planned to introduce a ready-to-mix protein powder and a functional beverage featuring TurtleTree's animal-free lactoferrin in the first quarter of 2025, highlighting the strong market readiness for these cutting-edge alternatives.

Key Market Players

• Hilmar Cheese Co Inc
• Pharming Group NV
• Royal FrieslandCampina N.V.
• Synlait Milk Ltd
• Ingredia SA
• MP Biomedicals LLC
• Tatura Milk Industries Ltd
• Glanbia PLC
• APS BioGroup Inc
• ProHealth Care Inc

Report Scope

In this report, the Global Lactoferrin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactoferrin Market, By Function

• Iron Absorption
• Anti-inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Lactoferrin Market, By Application

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Lactoferrin Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactoferrin Market.

Available Customizations:

Global Lactoferrin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lactoferrin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidant)
  • 5.2.2. By Application (Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, Animal Feed)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Lactoferrin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Function
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lactoferrin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Function
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Lactoferrin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Function
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Lactoferrin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Function
      • 6.3.3.2.2. By Application

7. Europe Lactoferrin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Function
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lactoferrin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Function
      • 7.3.1.2.2. By Application
  • 7.3.2. France Lactoferrin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Function
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Lactoferrin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Function
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Lactoferrin Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Function
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Lactoferrin Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Function
      • 7.3.5.2.2. By Application

8. Asia Pacific Lactoferrin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Function
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Lactoferrin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Function
      • 8.3.1.2.2. By Application
  • 8.3.2. India Lactoferrin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Function
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Lactoferrin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Function
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Lactoferrin Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Function
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Lactoferrin Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Function
      • 8.3.5.2.2. By Application

9. Middle East & Africa Lactoferrin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Function
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Lactoferrin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Function
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Lactoferrin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Function
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Lactoferrin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Function
      • 9.3.3.2.2. By Application

10. South America Lactoferrin Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Function
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Lactoferrin Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Function
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Lactoferrin Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Function
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Lactoferrin Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Function
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Lactoferrin Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hilmar Cheese Co Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pharming Group NV
• 15.3. Royal FrieslandCampina N.V.
• 15.4. Synlait Milk Ltd
• 15.5. Ingredia SA
• 15.6. MP Biomedicals LLC
• 15.7. Tatura Milk Industries Ltd
• 15.8. Glanbia PLC
• 15.9. APS BioGroup Inc
• 15.10. ProHealth Care Inc

16. Strategic Recommendations

17. About Us & Disclaimer